Hemorheological changes in children with familial hypercholesterolemia

Clinical Hemorheology and Microcirculation

Volumn 16, Issue 4, 1996, Pages 549-557

  Vayà, Amparo ^a   Martínez, Marcial ^a   Dalmau, Jaime ^b   Velert, Ma Mar ^a   Aznar, Justo ^a  

^a Department of Clinical Pathology ^*  (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Children; Erythrocyte aggregation; Familial hypercholesterolemia; Fibrinogen; Plasma viscosity; Rheology

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; FIBRINOGEN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL;

EID: 0029824317     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-1996-16410     Document Type: Article

References (38)

1. LEONHARDT H, ARNTZ HR, KLEMENS UH. Studies of plasma viscosity in primary hyperlipoproteinemia. Atherosclerosis. 28, 29-40, 1977.
2. LOWE G, Mc ARDLE B, STROMBERG P, LORIMER AD, FORBES S I PRENTICE CR. Increased blood viscosity and fibrinolytic activity in type II hyperlipoproteinemia. Lancet. 1, 472-475, 1982.
3. STOLTZ JF, GAILLARD S, ROUSELLE D, VOISIN P, DROWIN P. Rheological study of blood during primary hyperlipoproteinemia. Clin Hemorheol. 1, 227-232, 1981.
4. JAY RH, RAMPLING MW, BETTERIDGE DJ. Abnormalities of blood rheology in familial hypercholesterolemia: effects of treatment. Atherosclerosis. 85, 249-256, 1990.
5. VAYA A, MARTINEZ M, CARMENA R, AZNAR J. The lipid composition of red blood cells and their hemorheological behavior in patients with primary hyperlipoproteinemia. Clin Hemorheol. 13, 447-457, 1993.
6. VAYA A, MARTINEZ M, SANTOS MT, VALLES J, LLOPIS I, AZNAR J. Lipid peroxides and red blood cell deformability in familiar hypercholesterolemia. Clin Hemorheol. 15, 677-680, 1995.
7. JAY RH, Mc CARTHY SN, RAMPLING MW, BETTERIDGE DJ. Blood rheology and fibrinogen in children with familial hypercholesterolemia. Atherosclerosis. 91, 117-121, 1991.
8. VAYA A, MARTINEZ M, AZNAR J, GILSANZ A, BARBERA JL. Hemorheological profile in primary hyperlipemic patients wi th and without ischemic events. Rev Iberoamer Tromb Haemostas. 8, 74-77, 1995.
9. KOENIG W, SUND M, ERNST E, MRAZ W, HOMBARCH V, ULRICH K. Association between rheology and components of lipoproteins in human blood. Circulation. 85, 2197-2204, 1992.
10. HERNANDEZ M, CASTELLET J, NARVAIZA JL, RINCON JM, RUIZ I, SANCHEZ E, SOBRADILLO B, ZURIMENDI A. Curvas y tablas de crecimiento. M. Hernandez (eds). En Alimentación Infantil. Madrid. Diaz de Santos. 319-337, 1993
11. CORTNER JA, COALES PM, GALLGHER PRO Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr. 116, 514-519, 1990.
12. National cholesterol education program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics. 89, (Suppl) 525-584, 1992.
13. Guidelines for measurement of blood viscosity and erythrocyte deformability. International Committee for standarization in Haematology. Expert panel on blood rheology. Clin Hemorheol, 6, 439-453, 1986.
14. WARNICK GR, ABERS JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lip Res. 19, 65-76, 1978.
15. FRIEDEWALD WT, LEWY IR, FREDRICHSON DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chern. 18, 499-502, 1972.
16. HEUCK CC, SCHLIERF G. Nephelometry of apolipoprotein B in human serum. Clin Chern. 25, 221-226, 1979.
17. LABEUR C, MICHIELS G, BORG J. Lipoprotein(a) quantified by an enzyme linked inmunoabsorbent assay with monoclonal antibodies. Clin Chern. 35, 1380-1384, 1989.
18. SCHMID-SCHONBEIN H, VOLGER E, TEITEL P, KIESEWETTER H, DAVER V and HEILMANN L. New hemorheological techniques for the routine laboratory. Clin Hemorheol. 2, 93-95, 1983.
19. JUNG F, ROGGENKAMP HG, SCHNEIDER R and KIESEWETTER H. Das Kapillarschlauch-Plasmaviskosimeter ein neues Messgeri:it zur Quantifizierung der Blutplasmaviskositi:it. Biomed Technik. 28, 249-252, 1983.
20. ROSS R. The pathogenesis of atherosclerosis. An update. New Engl J Med. 314, 488-500, 1986.
21. LOWE R. Blood rheology in arterial disease. Clin Sci. 71, 137-146, 1986.
22. STUART J, GEORGE AJ, DAVIES AJ, AUKLAND A, HURLOW RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol. 34, 464-467, 1981.
23. DALMAU J, MONTERO C, BRETO M. Dificultad del tratamiento farmacol6gico en la hipercolesterolemia familiar heterocigota en pacientes pediátricos. An Esp Pediatr. 40, 209-214, 1994.
24. LOWE G.D.O. Blood viscosity, lipoproteins and cardiovascular risk. Circulation. 85, 2329-2331, 1992.
25. SEPLOWITZ AH, CHIEN S, SMITH FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis. 38, 89-95, 1981.
26. VAYA A, MARTINEZ M, CARMENA R, AZNAR J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res. 72, 119-126, 1993.
27. SCHUFF-WERNER P, SCHUTZ E, SEIDEL D. LDL-cholesterol, an underestimated determinant of plasma viscosity? Clin Hemorheol. 9, 525 (abstrast), 1989.
28. RUHENSTROTH-BAUER G, MOSSMER G, OTTL J, KOENIG-ERICH S, HEINEMANN G. Heigly significant negative correlations between erythrocyte aggregation value and serum value concentration of high density lipoprotein cholesterol in a sample from a normal population and in patients with coronary heart disease. Eur J Clin Invest. 17, 275-279, 1987.
29. RAZAVIAN SM, ATGER V, GIRAL M, CAMBILLAU M, DEL-PINO M, SIMON AC, MOATTI J, LEVENSON J. Influence of HDL subfractions on erythrocyte aggregation in hypercholesterolemic men. Arterioscl Thromb. 14, 361-366, 1994.
30. ERNST E. Plasma fibrinogen-an independent cardiovascular risk factor. J Int Med. 227, 365-372, 1994.
31. LOWE GDO. Blood viscosity and cardiovascular disease. Thromb Haemostas. 67, 494-498, 1992.
32. PUJIA A, RUBBA P, SPENCER MP. Prevalence of plaques and stenoses detectable by echo-Doppler examination in the femoral arteries of an elderly population. Atherosclerosis. 105, 201-208, 1994.
33. SCHUSTER HM, KRONER KK, KELLER C, SPENGEL FA, WOLFRAM G, ZOLLNER N. Atherosclerosis of the carotid arteries documented by Duplex Scan as a predictor of coronary artery disease in familial hyperlipidemias. Klin Wschr. 65, 34-39, 1987.
34. STARY HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. (Suppl I) 9, 19-31, 1989.
35. CELERMAJER DS, SORENSEN KE, GOOCH VM, SPIEGELHALTER DJ, MILLER OI, SULLIVAN ID, LLOYD JK, DEANFIELD JE. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340, 1111-1115, 1992.
36. CHIEN S, SUNG LA. Physico chemical basic and clinical implications of red cell aggregation. Clin Hemorheol. 7, 71-92, 1987.
37. STOLTZ JF, DONNER M. Erythrocyte aggregation. Experimental approaches and clinical implications. Intern Angiol. 6, 193-201, 1987.
38. TANAHASHI N, GOTOH I, TOMITA M, SHINOHARA T, TERAYAMA Y. MIHARA B, OTHA K, NARA M. Enhanced erythrocyte aggregability in occlusive cerebro-vascular disease. Stroke. 20, 1202-1207, 1989.